Waiting for your testing results-

If you were tested with Honu and still waiting for a test result, please call 855-873-6996 or email covid19help@honumg.com


Click the links below for information:

COVID-19 Community Levels

Where can I get COVID-19 Tested?
What to do if you're exposed to COVID-19
What to do if you're diagnosed with COVID-19

Questions and inquiries can be emailed to hotline@bldhd.org



Michigan's COVID-19 CASE DATA

COVID-19 Case Dashboard

MIsafestart Map

K-12 Aged ISD Reporting


COVID-19 Vaccine

MDHHS COVID-19 Vaccine Information 

CDC COVID-19 Vaccine Information

COVID-19 Vaccine Finder


Booster Dose Information: 

Boosters are shots that enhance or restore protection against COVID-19, which may have decreased over time. You are up to date with your COVID-19 vaccines when you have received all doses in the primary series and all boosters recommended for you, when eligible. 

Use CDC’s COVID-19 booster tool to learn if and when you can get boosters to stay up to date with your COVID-19 vaccines. 

Updated (Bivalent) Boosters 

The updated (bivalent) boosters are called “bivalent” because they protect against both the original virus that causes COVID-19 and the Omicron variant BA.4 and BA.5. 

Previous boosters are called “monovalent” because they were designed to protect against the original virus that causes COVID-19. They also provide some protection against Omicron, but not as much as the updated (bivalent) boosters. 

Two COVID-19 vaccine manufacturers, Pfizer and Moderna, have developed updated (bivalent) COVID-19 boosters. 

Who should receive a booster does? 

People ages 6 months and older are recommended to receive 1 bivalent mRNA booster dose after completion of any FDA-approved or FDA-authorized primary series or previously received monovalent booster dose(s) with the following exception: children 6 months–4 years who receive a 3-dose Pfizer-BioNTech primary series are not authorized to receive a booster dose at this time regardless of which Pfizer-BioNTech vaccine (i.e., a monovalent or bivalent) was administered for the third primary series dose. Monovalent mRNA vaccines are not authorized as a booster dose. 

A monovalent Novavax booster dose (instead of a bivalent mRNA booster dose) may be used in limited situations in people ages 18 years and older who completed any FDA-approved or FDA-authorized monovalent primary series, have not received any previous booster dose(s), and are unable (i.e., contraindicated or not available) or unwilling to receive an mRNA vaccine and would otherwise not receive a booster dose. 

Summary of recent changes (last updated December 9, 2022): 

  • New recommendation for children ages 6 months–4 years who complete a Moderna primary series to receive 1 bivalent Moderna booster dose at least 2 months after completion of the primary series. 
  • Children age 5 years who complete a Moderna primary series may receive either the previously authorized bivalent Pfizer-BioNTech booster dose or the newly authorized bivalent Moderna booster dose at least 2 months after completion of the Moderna primary series. 
  • The previously authorized 3-dose Pfizer-BioNTech primary series for children ages 6 months–4 years has been revised as follows: a monovalent Pfizer-BioNTech vaccine is administered for the first and second doses, followed by 1 bivalent Pfizer-BioNTech vaccine as the third primary series dose, at least 8 weeks after the second monovalent primary series dose. A booster dose is not authorized for children in this age group who receive a Pfizer-BioNTech 3-dose primary series, including children who previously received a 3-dose monovalent Pfizer-BioNTech primary series. 

What is the interval between the primary series and the bivalent mRNA booster dose? 

The bivalent booster dose is administered at least 2 months after completion of the primary series. The interval is the same regardless of which vaccine was administered for the primary series and which bivalent booster (Moderna or Pfizer-BioNTech) will be administered. 


COVID-19 Vaccine Updates


What is the health department doing in response to COVID-19?

The Benzie-Leelanau District Health Department is working with federal, state, and local partners to coordinate the response to COVID-19.  This includes investigation and contact tracing of newly diagnosed COVID-19 cases; coordination of testing for those who meet criteria; providing information to health care providers and the public; and planning and conducting COVID-19 vaccination clinics.


Daily Updates: 

Update 5-17-2022     Update 5-10-2022    Update 5-3-2022

Update 4-26-2022    Update 4-19-2022    Update 4-12-2022     Update 4-5-2022     Update 3-22-2022

Update 3-15-2022    Update 3-8-2022       Update 3-1-2022     Update 2-22-2022     Update 2-15-2022

Update 2-8-2022     Update 2-1-2022      Update 1-25-2022    Update 1-20-2022    Update 1-17-2022

Update 1-12-2022   Update 1-10-2022     Update 1-6-2022       Update 1-3-2022     Update 12-27-2021

Update 12-20-2021 Update 12-16-2021   Update 12-13-2021   Update 12-9-2021     Update 12-6-2021

Update 12-2-2021   Update 11-26-2021  Update 11-24-2021  Update 11-22-2021   Update 11-18-2021

Update 11-15-2021  Update 11-8-2021     Update 11-4-2021   Update 11-1-2021   Update 10-28-2021

Update 10-25-2021 Update 10-21-2021 Update 10-18-2021  Update 10-14-2021  Update 10-11-2021

Update 10-7-2021   Update 10-4-2021   Update 9-30-2021   Update 9-27-2021    Update 9-22-2021

Update 9-16-2021    Update 9-9-2021     Update 9-7-2021      Update 9-2-2021    Update 8-30-2021

Update 8-26-2021   Update 8-23-2021    Update 8-19-2021   Update 8-16-2021   Update 8-12-2021

Update 8-9-2021     Update 8-5-2021     Update 8-2-2021      Update 7-29-2021    Update 7-26-2021

Update 7-22-2021​   Update 7-19-2021    Update 7-15-2021   Update 7-12-2021    Update 7-8-2021

Update 7-6-2021     Update 7-1-2021     Update 6-28-2021    Update 6-24-2021   Update 6-21-2021

Update 6-17-2021   Update 6-14-2021    Update 6-10-2021    Update 6-7-2021     Update 6-3-2021

Update 6-1-2021     Update 5-27-2021   Update 5-24-2021   Update 5-21-2021  Update 5-20-2021

Update 5-19-2021  Update 5-18-2021    Update 5-17-2021    Update 5-14-2021    Update 5-13-2021

Update 5-12-2021   Update 5-11-2021    Update 5-10-2021    Update 5-7-2021     Update 5-6-2021

Update 5-5-2021     Update 5-4-2021     Update 5-3-2021      Update 4-30-2021     Update 4-29-2021

Update 4-28-2021     Update 4-27-2021    Update 4-26-2021    Update 4-23-2021   Update 4-22-2021

Update 4-21-2021    Update 4-20-2021     Update 4-19-2021    Update 4-16-2021    Update 4-15-2021

Update 4-14-2021   Update 4-13-2021      Update 4-12-2021     Update 4-9-2021     Update 4-8-2021

Update 4-7-2021     Update 4-6-2021       Update 4-5-2021         Update 4-1-2021       Update 3-31-2021

Update 3-30-2021   Update 3-29-2021     Update 3-26-2021      Update 3-25-2021      Update 3-24-2021

Update 3-23-2021    Update 3-22-2021     Update 3-19-2021     Update 3-18-2021      Update 3-17-2021

Update 3-16-2021    Update 3-15-2021     Update 3-12-2021      Update 3-11-2021      Update 3-10-2021

Update 3-9-2021       Update 3-8-2021        Update 3-5-2021        Update 3-4-2021       Update 3-3-2021

Update 3-2-2021       Update 3-1-2021        Update 2-26-2021      Update 2-25-2021     Update 2-24-2021

Update 2-23-2021     Update 2-22-2021    Update 2-19-2021       Update 2-18-2021      Update 2-17-2021

Update 2-16-2021     Update 2-12-2021      Update 2-11-2021     Update 2-10-2021      Update 2-9-2021

Update 2-8-2021        Update 2-5-2021        Update 2-4-2021        Update 2-3-2021       Update 2-2-2021

Update 2-1-2021      Update 1-29-2021     Update 1-28-2021      Update 1-27-2021       Update 1-26-2021

Update 1-25-2021     Update 1-22-2021      Update 1-21-2021       Update 1-20-2021     Update 1-19-2021

Update 1-18-2021      Update 1-15-2021       Update 1-14-2021      Update 1-13-2021      Update 1-12-2021

Update 1-11-2021      Update 1-8-2021          Update 1-7-2021         Update 1-6-2021         Update 1-5-2021

Update 1-4-2021 


Press Releases and other Communication

Archived COVID-19 Related Releases

Archived 2020 COVID-19 Update Releases


What Should Individuals Be Doing To Protect Themselves?

The best way to protect yourself and others from COVID-19 is to follow the same general guidelines to protect yourself from flu and other common illnesses.

  • Wash your hands with soap and water frequently, especially before eating, before touching your face/eyes/mouth, after coughing or sneezing, and after touching surfaces that have been touched by many others.  Wash for at least 20 seconds.  if soap and water are not available, use hand sanitizer.
  • Avoid touching your eyes, nose, and mouth
  • Cover your cough/sneeze with a tissue
  • Clean frequently touched objects with regular household cleaners
  • Stay home if you are ill
  • Get Vaccinated when eligible
  • Wear a face mask indoors. Face Covering Guidance


COVID-19 Information Hotlines

MDHHS Hotline: 1-888-535-6136 or email COVID19@michigan.gov
(Experts answering COVID-19-related questions - Open 8:00 AM - 5:00 PM, 7 days a week)

Munson Healthcare COVID-19 Hotline: 231-935-0951
(Signs & Symptoms of COVID-19, Options to speak with a Munson Team Member - Recording available 24/7)

2-1-1 Hotline
(Get connected with needed resources from across our communities - Calls - 24 hours, Text & Chat, 8:00 AM - 5:00 PM, Monday - Friday)


Guidance and Recommended Information

Where to find updated information about COVID-19:

Michigan Department of Health and Human Services (MDHHS)

Centers for Disease Control (CDC)

Household and Family Information:

           Symptoms of COVID-19

            If You Are Sick or Caring for Someone

            Treatments and Theraputics

            CDC- Isolation & Quarantine guidance

            Pregnant and Recently Pregnant People and COVID-19

            Multi-system Inflammatory Syndrome in Children (MIS-C)

            Traveler Information

           MDHHS K-12 Schools Guidance